Literature DB >> 35210605

Omicron's lasting mysteries: four questions scientists are racing to answer.

Amber Dance.   

Abstract

Entities:  

Keywords:  SARS-CoV-2; Virology

Mesh:

Substances:

Year:  2022        PMID: 35210605     DOI: 10.1038/d41586-022-00428-5

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   69.504


× No keyword cloud information.
  5 in total

1.  SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo.

Authors:  Kenrie P Y Hui; John C W Ho; Man-Chun Cheung; Ka-Chun Ng; Rachel H H Ching; Ka-Ling Lai; Tonia Tong Kam; Haogao Gu; Ko-Yung Sit; Michael K Y Hsin; Timmy W K Au; Leo L M Poon; Malik Peiris; John M Nicholls; Michael C W Chan
Journal:  Nature       Date:  2022-02-01       Impact factor: 49.962

2.  In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2.

Authors:  Agnieszka M Szemiel; Andres Merits; Richard J Orton; Oscar A MacLean; Rute Maria Pinto; Arthur Wickenhagen; Gauthier Lieber; Matthew L Turnbull; Sainan Wang; Wilhelm Furnon; Nicolas M Suarez; Daniel Mair; Ana da Silva Filipe; Brian J Willett; Sam J Wilson; Arvind H Patel; Emma C Thomson; Massimo Palmarini; Alain Kohl; Meredith E Stewart
Journal:  PLoS Pathog       Date:  2021-09-17       Impact factor: 6.823

3.  The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters.

Authors:  Rana Abdelnabi; Caroline S Foo; Xin Zhang; Viktor Lemmens; Piet Maes; Bram Slechten; Joren Raymenants; Emmanuel André; Birgit Weynand; Kai Dallmeier; Johan Neyts
Journal:  Antiviral Res       Date:  2022-01-21       Impact factor: 5.970

4.  T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant.

Authors:  Seong Jin Choi; Dong-Uk Kim; Ji Yun Noh; Sangwoo Kim; Su-Hyung Park; Hye Won Jeong; Eui-Cheol Shin
Journal:  Cell Mol Immunol       Date:  2022-01-18       Impact factor: 11.530

5.  Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates.

Authors:  Denisa Bojkova; Marek Widera; Sandra Ciesek; Mark N Wass; Martin Michaelis; Jindrich Cinatl
Journal:  Cell Res       Date:  2022-01-21       Impact factor: 25.617

  5 in total
  1 in total

Review 1.  COVID-19: Omicron - the latest, the least virulent, but probably not the last variant of concern of SARS-CoV-2.

Authors:  Harald Brüssow
Journal:  Microb Biotechnol       Date:  2022-04-20       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.